SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc.

SABS
SAB Biotherapeutics, Inc.US flagNASDAQ
3.64
USD
+0.13
- -
34.79MMarket Cap

SAB Biotherapeutics, Inc. (SABS) Stock Split History

Learn about SAB Biotherapeutics, Inc.'s most recent 1-for-10 basis stock split on January 05, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about SAB Biotherapeutics, Inc.'s most recent stock split

Split Date: 2024-01-05
Split Ratio: 1:10
Price Before Split: $0.58
Price After Split: $0.06

Developer API

Get SABS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/SABS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of SAB Biotherapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-01-051:10Yes$0.58$0.06

About SAB Biotherapeutics, Inc.

Company overview and industry information

SAB Biotherapeutics, Inc. (SABS) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to SAB Biotherapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.